Johnson & Johnson (JNJ) Operating Expenses (2009 - 2026)

Johnson & Johnson has disclosed Operating Expenses across 18 years of filings, most recently posting $9.6 billion for Q1 2026.

• Operating Expenses for Q1 2026 came in at $9.6 billion, up 14.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.3 billion (down 36.43% YoY), and the FY2025 annual result was $24.0 billion, down 40.47% from the prior year.
• Operating Expenses came in at $9.6 billion for Q1 2026 at Johnson & Johnson, up from -$3.5 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $11.8 billion in Q4 2024 to a low of -$10.6 billion in Q1 2022.
• The 5-year median for Operating Expenses is $9.1 billion (2023), against an average of $6.6 billion.
• Across the five-year window, Operating Expenses tumbled 261.96% in 2022 and soared 377.09% in 2024, its largest moves.
• Johnson & Johnson's Operating Expenses stood at $8.5 billion in 2022, then plunged by 149.92% to -$4.3 billion in 2023, then surged by 377.09% to $11.8 billion in 2024, then sank by 129.4% to -$3.5 billion in 2025, then surged by 376.69% to $9.6 billion in 2026.
• The last three Operating Expenses figures came in at $9.6 billion (Q1 2026), -$3.5 billion (Q4 2025), and $9.7 billion (Q3 2025), per Business Quant data.